Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

Fakeeh Care Group and Fosun Pharma sign strategic partnership

Fakeeh Care Group, a healthcare service provider in Saudi Arabia, and Fosun Pharma, an innovation-driven global healthcare company, have forged a strategic partnership to advance cell and gene therapy and tele-diagnostics in Saudi Arabia.
May 1, 2025

NHS app becomes default route for GP registration

UK NHS patients can now instantly register with a GP on the NHS APP, and will soon be able to view and manage hospital appointments, and select from a greater number of providers, including independent sector providers, and receive test results straight through the app.
April 24, 2025

KKR offers $1.2 billion for Sweden’s Biotage

RWK BidCo, a newly formed company wholly owned by global investment firm KKR Funds with the purpose of making the offer in deals, has announced a recommended public offer to the shareholders of Biotage, valuing it at around 1.6 billion SEK ($1.22 billion).
April 24, 2025

DCC to sell healthcare division for £1.05 billion

DCC, A Dublin-based and London Stock Exchange-listed sales, marketing and support services group, has announced it has entered into a definitive agreement to sell its healthcare division to HealthCo, an investment vehicle of funds managed by European private equity firm Investindustrial Advisors, for £1.05 billion (approximately €1.23 billion).
April 24, 2025

‘Saudization’ kickstarts in Saudi Arabia’s healthcare sector

The first phase of ‘Saudization’ in Saudi Arabia’s healthcare sector is now underway, effective from 17 April. Saudization is a government policy to increase the number of Saudi nationals employed and reduce the reliance on expats in the workforce. 
April 24, 2025

Chaos and opportunity — The impact of Trump’s trade war on Europe’s healthcare sector

Europe’s healthcare providers are less directly exposed to Donald Trump’s trade war than its med tech sector. But hospital and outpatient groups will still suffer. The severity of the pain will depend largely on the EU’s response to US tariffs, in particular the level and extent of possible counter tariffs. The EU could also be galvanised into better supporting innovation and R&D in its med tech and pharma sectors.
April 24, 2025
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us